Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply
- PMID: 32338780
- DOI: 10.1111/apt.15696
Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply
Comment on
-
Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease.Aliment Pharmacol Ther. 2020 Apr;51(7):728-736. doi: 10.1111/apt.15660. Epub 2020 Feb 11. Aliment Pharmacol Ther. 2020. PMID: 32043602 Free PMC article.
-
Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis?Aliment Pharmacol Ther. 2020 May;51(10):987-988. doi: 10.1111/apt.15682. Aliment Pharmacol Ther. 2020. PMID: 32338785 No abstract available.
References
REFERENCES
-
- Horn P, Newsome PN. Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Aliment Pharmacol Ther. 2020;51:987-988.
-
- Henson JB, Simon TG, Kaplan A, Osganian S, Masia R, Corey KE. Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2020;51:728-736.
-
- Alexander M, Loomis AK, van der Lei J, et al. Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults. BMJ. 2019;367:l5367.
-
- Henson JB, Roden M, Targher G, Corey KE. Is NAFLD not a risk factor for cardiovascular disease: not yet time for a change of heart. Hepatology. 2020;https://doi.org/10.1002/hep.31156 [Epub ahead of print]
Publication types
MeSH terms
LinkOut - more resources
Medical